{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T18:11:17Z","timestamp":1765995077985},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,16]]},"DOI":"10.7759\/cureus.32600","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T17:41:08Z","timestamp":1671212468000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Plasmablastic Multiple Myeloma With Extramedullary Disease Manifesting as a Myelomatous Pleural Effusion"],"prefix":"10.7759","author":[{"given":"Mohamed Zakee","family":"Mohamed Jiffry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Ahmed-khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Napat","family":"Rangsipat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Galligani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"De La Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar SV","year":"2022","unstructured":"Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022, 97:1086-107. 10.1002\/ajh.26590","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5851.68850","article-title":"Multiple cystic swelling: Initial presentation of multiple myeloma","volume":"31","author":"Kumar S","year":"2010","unstructured":"Kumar S, Jain AP, Waghmare S. Multiple cystic swelling: Initial presentation of multiple myeloma. Indian J Med Paediatr Oncol. 2010, 31:28-9. 10.4103\/0971-5851.68850","journal-title":"Indian J Med Paediatr Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.31782\/IJCRR.2021.131716","article-title":"Multiple myeloma presenting as fatal hyperviscosity syndrome: a rare case report","volume":"13","author":"Bhagawati J","year":"2021","unstructured":"Bhagawati J, Agrawal K, Kumar S, Acharya S. Multiple myeloma presenting as fatal hyperviscosity syndrome: a rare case report. Int J Curr Res Rev. 2021, 13:n\/a. 10.31782\/IJCRR.2021.131716","journal-title":"Int J Curr Res Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00643-3","article-title":"Extramedullary disease in multiple myeloma: a systematic literature review","volume":"12","author":"Blad\u00e9 J","year":"2022","unstructured":"Blad\u00e9 J, Beksac M, Caers J, et al.. Extramedullary disease in multiple myeloma: a systematic literature review. Blood Cancer J. 2022, 12:45. 10.1038\/s41408-022-00643-3","journal-title":"Blood Cancer J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/15330338221132370","article-title":"Clinical characteristics and prognosis of multiple myeloma with myelomatous pleural effusion: a retrospective single-center study","volume":"21","author":"Gao L","year":"2022","unstructured":"Gao L, Xu J, Xie W, Wang B, Cen X, Wang M. Clinical characteristics and prognosis of multiple myeloma with myelomatous pleural effusion: a retrospective single-center study. Technol Cancer Res Treat. 2022, 21:15330338221132370. 10.1177\/15330338221132370","journal-title":"Technol Cancer Res Treat"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.55.4733","article-title":"Pleural effusion in multiple myeloma","volume":"55","author":"Wang Z","year":"2016","unstructured":"Wang Z, Xia G, Lan L, et al.. Pleural effusion in multiple myeloma. Intern Med. 2016, 55:339-45. 10.2169\/internalmedicine.55.4733","journal-title":"Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.18231\/2348-7240.2018.0009","article-title":"Multiple myeloma presenting as pleural effusion in elderly","volume":"5","author":"Yogesh K","year":"2020","unstructured":"Yogesh K, Sunil K, Nitin R, et al.. Multiple myeloma presenting as pleural effusion in elderly. Ann Geriatr Educ Med Sci. 2020, 5:36-37. 10.18231\/2348-7240.2018.0009","journal-title":"Ann Geriatr Educ Med Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(98)80068-X","article-title":"Incidence and pattern of liver involvement in haematological malignancies","volume":"194","author":"Walz-Mattm\u00fcller R","year":"1998","unstructured":"Walz-Mattm\u00fcller R, Horny HP, Ruck P, Kaiserling E. Incidence and pattern of liver involvement in haematological malignancies. Pathol Res Pract. 1998, 194:781-789. 10.1016\/S0344-0338(98)80068-X","journal-title":"Pathol Res Pract"},{"key":"ref9","article-title":"Clinical and biological features of multiple myeloma involving the gastrointestinal system","volume":"91","author":"Talamo G","year":"2006","unstructured":"Talamo G, Cavallo F, Zangari M, et al.. Clinical and biological features of multiple myeloma involving the gastrointestinal system. Haematologica. 2006, 91:964-7.","journal-title":"Haematologica"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-022-03353-5","article-title":"Multiple myeloma with high-risk cytogenetics and its treatment approach","volume":"115","author":"Hanamura I","year":"2022","unstructured":"Hanamura I. Multiple myeloma with high-risk cytogenetics and its treatment approach. Int J Hematol. 2022, 115:762-77. 10.1007\/s12185-022-03353-5","journal-title":"Int J Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.023697","article-title":"Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma","volume":"95","author":"Lod\u00e9 L","year":"2010","unstructured":"Lod\u00e9 L, Eveillard M, Trichet V, et al.. Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma. Haematologica. 2010, 95:1973-6. 10.3324\/haematol.2010.023697","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-019-0254-0","article-title":"Gain of chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone","volume":"9","author":"Schmidt TM","year":"2019","unstructured":"Schmidt TM, Barwick BG, Joseph N, et al.. Gain of chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone. Blood Cancer J. 2019, 9:94. 10.1038\/s41408-019-0254-0","journal-title":"Blood Cancer J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02515","article-title":"Long-term follow-up results of lenalidomide, bortezomib, and dexamethasone induction therapy and risk-adapted maintenance approach in newly diagnosed multiple myeloma","volume":"38","author":"Joseph NS","year":"2020","unstructured":"Joseph NS, Kaufman JL, Dhodapkar MV, et al.. Long-term follow-up results of lenalidomide, bortezomib, and dexamethasone induction therapy and risk-adapted maintenance approach in newly diagnosed multiple myeloma. J Clin Oncol. 2020, 38:1928-37. 10.1200\/JCO.19.02515","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.2139.2139","article-title":"Bortezomib in combination with dexamethasone, cyclophosphamide, etoposide, and cisplatin (V-DCEP) for the treatment of multiple myeloma","volume":"124","author":"Valla K","year":"2014","unstructured":"Valla K, Kaufman J, Gleason C, et al.. Bortezomib in combination with dexamethasone, cyclophosphamide, etoposide, and cisplatin (V-DCEP) for the treatment of multiple myeloma. Blood. 2014, 124:2139. 10.1182\/blood.V124.21.2139.2139","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00040","article-title":"Current role of radiation therapy for multiple myeloma","volume":"5","author":"Talamo G","year":"2015","unstructured":"Talamo G, Dimaio C, Abbi KK, et al.. Current role of radiation therapy for multiple myeloma. Front Oncol. 2015, 5:40. 10.3389\/fonc.2015.00040","journal-title":"Front Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/128618-a-case-of-plasmablastic-multiple-myeloma-with-extramedullary-disease-manifesting-as-a-myelomatous-pleural-effusion","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:17Z","timestamp":1707508337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/128618-a-case-of-plasmablastic-multiple-myeloma-with-extramedullary-disease-manifesting-as-a-myelomatous-pleural-effusion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,16]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.32600","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,16]]}}}